168 related articles for article (PubMed ID: 578613)
1. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone in children: normal children and HGH-treated pituitary dwarfs.
Garnier PE; Job JC
Acta Endocrinol (Copenh); 1977 Sep; 86(1):50-9. PubMed ID: 578613
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
LaFranchi S; Hanna CE; Jelen B
Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
[TBL] [Abstract][Full Text] [Related]
3. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
[TBL] [Abstract][Full Text] [Related]
4. Radioreceptor-inactive growth hormone associated with stimulated secretion in normal subjects.
Sneid DS; Jacobs LS; Weldon VV; Trivedi BL; Daughaday H
J Clin Endocrinol Metab; 1975 Sep; 41(3):471-4. PubMed ID: 169286
[TBL] [Abstract][Full Text] [Related]
5. Growth failure with plasma GH that is normal by RIA but low by radioreceptor assay: responsiveness to exogenous GH.
Bistritzer T; Chalew SA; Kowarski AA
Horm Res; 1995; 43(6):261-5. PubMed ID: 7607611
[TBL] [Abstract][Full Text] [Related]
6. Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue.
Eshet R; Peleg S; Josefsberg Z; Fuchs C; Arnon R; Laron Z
Horm Res; 1985; 22(4):276-83. PubMed ID: 3000911
[TBL] [Abstract][Full Text] [Related]
7. Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone.
Gavin JR; Trivedi B; Daughaday WH
J Clin Endocrinol Metab; 1982 Jul; 55(1):133-9. PubMed ID: 6281300
[TBL] [Abstract][Full Text] [Related]
8. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone in children. II: Primary, genetic and intra-uterine growth retardation.
Garnier PE; Repellin AM; Job JC
Acta Endocrinol (Copenh); 1978 Jun; 88(2):227-38. PubMed ID: 580825
[TBL] [Abstract][Full Text] [Related]
9. A screening test to detect HGH-antibodies in pituitary dwarfs treated with HGH preparation by the radio-immunoassay with double antibody technique.
Okada Y; Takahashi T; Kumahara Y
Endocrinol Jpn; 1977 Dec; 24(6):589-93. PubMed ID: 606547
[TBL] [Abstract][Full Text] [Related]
10. Quantitative differences between immunological and receptor binding activities of hGH in pituitary adenomas from patients with acromegaly.
Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M
Endocrinol Jpn; 1984 Dec; 31(6):719-24. PubMed ID: 6099801
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) determinations by RIA and IFA during GH stimulation tests in children with short stature.
Kvaratskhelia E; Metreveli D; Koplatadze K; Virsaladze D; Willig R
Georgian Med News; 2006 Nov; (140):51-4. PubMed ID: 17179589
[TBL] [Abstract][Full Text] [Related]
12. Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay.
Kemp SF; Rosenfeld RG; Liu F; Gaspich S; Hintz RL
J Clin Endocrinol Metab; 1981 Apr; 52(4):616-21. PubMed ID: 7204536
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
Takano K; Hizuka N; Shizume K; Hasumi Y
Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of radioimmunoassay and radioreceptor assay of serum growth hormone in children with growth disorders (author's transl)].
Maesaka H; Suwa S
Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):164-70. PubMed ID: 6989653
[No Abstract] [Full Text] [Related]
16. [Clinical application of serum insulin-like growth factor I (IGF-I)(26-46) radioimmunoassay--with special reference to the relationship between IGF(26-46) and growth hormone secretion].
Nakagawa Y
Nihon Naibunpi Gakkai Zasshi; 1985 Feb; 61(2):130-44. PubMed ID: 3891431
[TBL] [Abstract][Full Text] [Related]
17. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone.
Annerén G; Gustavson KH; Sara VR; Tuvemo T
Am J Med Genet Suppl; 1990; 7():59-62. PubMed ID: 1963538
[TBL] [Abstract][Full Text] [Related]
18. Influence of matrix on concentrations of somatotropin measured in serum with commercial immunoradiometric assays.
Felder RA; Holl RW; Martha P; Bauler G; Hellman P; Wills MR; Thorner MO
Clin Chem; 1989 Jul; 35(7):1423-6. PubMed ID: 2758587
[TBL] [Abstract][Full Text] [Related]
19. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.
Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK
N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948
[No Abstract] [Full Text] [Related]
20. Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency.
Giavoli C; Bergamaschi S; Ferrante E; Ronchi CL; Lania AG; Rusconi R; Spada A; Beck-Peccoz P
Clin Endocrinol (Oxf); 2008 Feb; 68(2):247-51. PubMed ID: 17868384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
